MCID: OBS001
MIFTS: 48

Obstructive Jaundice

Categories: Gastrointestinal diseases

Aliases & Classifications for Obstructive Jaundice

MalaCards integrated aliases for Obstructive Jaundice:

Name: Obstructive Jaundice 12 14
Jaundice, Obstructive 42 69
Obstructive Hyperbilirubinemia 12
Cholestatic Jaundice Syndrome 12
Obstructive Jaundice Nos 12
Cholestatic Jaundice 12
Jaundice Obstructive 52
Jaundice Cholestatic 52

Classifications:



External Ids:

Disease Ontology 12 DOID:13603
MeSH 42 D041781
NCIt 47 C34742
UMLS 69 C0022354

Summaries for Obstructive Jaundice

MalaCards based summary : Obstructive Jaundice, also known as jaundice, obstructive, is related to lymphoma and acute cholangitis, and has symptoms including icterus and jaundice (not of newborn). An important gene associated with Obstructive Jaundice is ALPP (Alkaline Phosphatase, Placental), and among its related pathways/superpathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Lactulose and Ceftriaxone have been mentioned in the context of this disorder. Affiliated tissues include liver, pancreas and lung, and related phenotypes are homeostasis/metabolism and liver/biliary system

Related Diseases for Obstructive Jaundice

Diseases related to Obstructive Jaundice via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 384)
id Related Disease Score Top Affiliating Genes
1 lymphoma 30.5 ALB CD79A IL6 TNF
2 acute cholangitis 29.9 ALB GPBAR1 TNF
3 gallbladder cancer 29.9 ALB F2 IL6 TNF
4 myeloid sarcoma 29.6 CXCL8 IL6 TNF
5 choroiditis 29.3 ALB CXCL8 IL6 TNF
6 hepatocellular carcinoma 28.1 ALB CXCL8 F2 GGT1 GPT HGF
7 lymphedema 27.1 ALB EDN1 F2 GGT1 GPT HGF
8 mirizzi syndrome 11.1
9 cholestasis, benign recurrent intrahepatic 11.0
10 cholestasis, benign recurrent intrahepatic, 2 10.9
11 bile acid synthesis defect, congenital, 1 10.9
12 adrenocorticotropic hormone deficiency 10.9
13 htra1-related autosomal dominant cerebral small vessel disease 10.9 GPT SLC17A5
14 midface dysplasia 10.8 ALB TTR
15 monosomy 13q34 10.8 IL6 REN
16 quinquaud's decalvans folliculitis 10.8 GPT SLC17A5
17 smarca4-deficient sarcoma of thorax 10.8 IL6 TNF
18 early-onset severe reducing body myopathy, x-linked 10.8 ALB TTR
19 wernicke-korsakoff syndrome 10.8 ALB REN
20 congenital dyserythropoietic anemia 10.8 ALB TNF
21 non-hodgkin lymphoma, during pregnancy 10.7 ALB F2
22 iga glomerulonephritis 10.7 ALB REN
23 aortic arch interruption 10.7 IL6 TNF
24 atrial septal defect 7, with or without av conduction defects 10.7 GGT1 REN
25 uterine inflammatory disease 10.7 EDN1 REN
26 argyria 10.7 F2 GPT
27 ampulla of vater neoplasm 10.6 IL6 SLC17A5 TNF
28 superior limbic keratoconjunctivitis 10.6 F2 IL6
29 levator syndrome 10.6 IL6 SLC17A5 TNF
30 neurogenic thoracic outlet syndrome 10.6 ALPP GPT
31 pyridoxine deficiency anemia 10.6 F2 REN
32 atopic dermatitis 5 10.6 ALB CD79A
33 papilledema 10.6 IL6 TNF TTR
34 microinvasive cervical squamous cell carcinoma 10.6 ALB CD79A
35 toxoplasmosis 10.6 IL6 TNF
36 megaloblastic anemia 10.6 GPT SLC17A5 TNF
37 ovary transitional cell carcinoma 10.6 ALB CD79A
38 hypervitaminosis a 10.6 CD79A TTR
39 fragile x syndrome type 2 10.6 ALB F2
40 plummer's disease 10.6 ALB IL6 TNF
41 cholangiolocellular carcinoma 10.6 F2 REN
42 rift valley fever 10.6 ALB IL6 TNF
43 hepatic infarction 10.6 EDN1 REN
44 chronic inflammatory demyelinating polyradiculoneuropathy 10.6 ALB GGT1 REN
45 burning mouth syndrome 10.6 F2 TNF
46 antiphospholipid syndrome 10.5 EDN1 REN
47 gastric ulcer 10.5 ALB IL6 TNF
48 alcoholic liver cirrhosis 10.5 GGT1 GPT SLC17A5
49 silver-russell syndrome due to 11p15 microduplication 10.5 EDN1 REN SLC17A5
50 ischemic heart disease 10.5 ALB F2 IL6

Graphical network of the top 20 diseases related to Obstructive Jaundice:



Diseases related to Obstructive Jaundice

Symptoms & Phenotypes for Obstructive Jaundice

UMLS symptoms related to Obstructive Jaundice:


icterus, jaundice (not of newborn)

MGI Mouse Phenotypes related to Obstructive Jaundice:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.93 ALB CD79A EDN1 F2 GGT1 GPBAR1
2 liver/biliary system MP:0005370 9.5 CD79A GPBAR1 HGF IL6 SLC25A13 TNF
3 renal/urinary system MP:0005367 9.23 ALB CD79A EDN1 GGT1 GPBAR1 IL6

Drugs & Therapeutics for Obstructive Jaundice

Drugs for Obstructive Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 56)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lactulose Approved Phase 4 4618-18-2 11333
2
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
3
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
4
Ofloxacin Approved Phase 4 82419-36-1 4583
5 Anti-Bacterial Agents Phase 4
6 Antibiotics, Antitubercular Phase 4
7 Anti-Infective Agents Phase 4
8 Antitubercular Agents Phase 4
9 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
10 Cytochrome P-450 Enzyme Inhibitors Phase 4
11 Renal Agents Phase 4
12 Topoisomerase Inhibitors Phase 4
13
Trioxsalen Approved Phase 2, Phase 3 3902-71-4 5585
14 Dihematoporphyrin Ether Phase 2, Phase 3
15 Hematoporphyrin Derivative Phase 2, Phase 3
16
Ursodeoxycholic acid Approved, Investigational Phase 2 128-13-2 31401
17
Neostigmine Approved, Vet_approved Phase 1, Phase 2 59-99-4 4456
18
Menthol Approved Phase 2 2216-51-5 16666
19
Pancrelipase Approved Phase 2 53608-75-6
20 Cholagogues and Choleretics Phase 2
21 Gastrointestinal Agents Phase 2
22 Liver Extracts Phase 2,Phase 1
23 Anti-Inflammatory Agents Phase 1, Phase 2
24 Autonomic Agents Phase 1, Phase 2
25 Cholinergic Agents Phase 1, Phase 2
26 Cholinesterase Inhibitors Phase 1, Phase 2
27 Neurotransmitter Agents Phase 1, Phase 2
28 Peripheral Nervous System Agents Phase 1, Phase 2
29
Bilirubin Phase 2,Phase 1 635-65-4 5280352
30 pancreatin Phase 2
31 Fat Emulsions, Intravenous Phase 1, Phase 2
32 Olive Nutraceutical Phase 1, Phase 2
33 Omega 3 Fatty Acid Nutraceutical Phase 1, Phase 2
34 Soy Bean Nutraceutical Phase 1, Phase 2
35
Sevoflurane Approved, Vet_approved 28523-86-6 5206
36
Prednisone Approved, Vet_approved 53-03-2 5865
37
Phenobarbital Approved 50-06-6 4763
38 Dermatologic Agents
39 Ether
40 Hematoporphyrins
41 Photosensitizing Agents
42 Anesthetics
43 Anesthetics, General
44 Anesthetics, Inhalation
45 Central Nervous System Depressants
46 Platelet Aggregation Inhibitors
47 Bile Acids and Salts
48 Antibodies
49 Immunoglobulins
50 Anticonvulsants

Interventional clinical trials:

(show all 46)

id Name Status NCT ID Phase Drugs
1 Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice Unknown status NCT00731419 Phase 4
2 Human Kidney Histopathology in Obstructive Jaundice Completed NCT01090193 Phase 4
3 Covered vs. Uncovered SEMS for Occluded Biliary Metal Stents Completed NCT01315522 Phase 4
4 Antibiotics to Decrease Post ERCP Cholangitis Recruiting NCT03087656 Phase 4 Ceftriaxone;Levofloxacin
5 Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice Unknown status NCT01744938 Phase 3
6 RFA RCT for Pancreatic or Bile Duct Cancer Unknown status NCT02166190 Phase 3
7 Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. Completed NCT00391183 Phase 2, Phase 3
8 Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures Recruiting NCT01721174 Phase 2, Phase 3
9 Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma Recruiting NCT01755013 Phase 2, Phase 3
10 Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction Withdrawn NCT01622803 Phase 3
11 The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice Unknown status NCT01688375 Phase 2 Ursodeoxycholic Acid
12 Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice Unknown status NCT01275768 Phase 1, Phase 2
13 Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation. Unknown status NCT02279147 Phase 1, Phase 2 neostigmine methylsulfate,raceanisodamine hydrochloride
14 Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy Unknown status NCT01941342 Phase 2
15 Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors. Completed NCT02166840 Phase 2
16 Radiofrequency Ablation for Biliopancreatic Malignancy Completed NCT02468076 Phase 2
17 SMOFlipid to Lessen the Severity of Neonatal Cholestasis Terminated NCT02721277 Phase 1, Phase 2 SMOFlipid
18 Immune Function in Patients With Obstructive Jaundice Unknown status NCT01367821
19 Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage Unknown status NCT01686425
20 Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice Unknown status NCT00155194
21 Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers Completed NCT01134276
22 Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma Completed NCT01506115 Photofrin
23 Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer Completed NCT00409864
24 Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP) Completed NCT01321203
25 Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) Completed NCT00196105
26 Biliary Atresia, Hepatic Buffer Response and Sevoflurane Completed NCT02471209 Sevoflurane
27 Early Versus Late Cholecystectomy After Clearance of Common Bile Duct Stones Completed NCT02460315
28 Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures Completed NCT01580709
29 Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional Cannulation Completed NCT02477228
30 Expression of BCRP in Icteric Patients Completed NCT00295360
31 Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids Recruiting NCT02797665 corticosteroids
32 Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression Recruiting NCT01191814
33 Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation Recruiting NCT03133026
34 Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression Recruiting NCT01675908
35 Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction Recruiting NCT02937246
36 The Necessity of Bile Cultures in Patients With Acute Cholangitis Recruiting NCT02601417
37 Study of Abdominal Drainage in LCBDE+PC Recruiting NCT03120754
38 A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction Recruiting NCT02659852
39 Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study Recruiting NCT02646514
40 EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent Recruiting NCT03002051
41 Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures Recruiting NCT03307382
42 Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders Recruiting NCT01438385
43 Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis Enrolling by invitation NCT02841800
44 Endoscopic Access Loop With Bilio-enteric Anastomosis: A Prospective Randomized Comparison Between Gastric and Subcutaneous Accesses Not yet recruiting NCT03252379
45 A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction Terminated NCT01514058
46 Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP Withdrawn NCT01439685

Search NIH Clinical Center for Obstructive Jaundice

Cochrane evidence based reviews: jaundice, obstructive

Genetic Tests for Obstructive Jaundice

Anatomical Context for Obstructive Jaundice

MalaCards organs/tissues related to Obstructive Jaundice:

39
Liver, Pancreas, Lung, Kidney, Brain, Lymph Node, Myeloid

Publications for Obstructive Jaundice

Articles related to Obstructive Jaundice:

(show top 50) (show all 722)
id Title Authors Year
1
An HIV-positive Case of Obstructive Jaundice Caused by Immune Reconstitution Inflammatory Syndrome of Tuberculous Lymphadenitis Successfully Treated with Corticosteroids. ( 28883243 )
2017
2
Endoscopic ultrasound for the diagnosis of an uncommon cause of obstructive jaundice masquerading as malignancy. ( 28663532 )
2017
3
Clinical Study on Using (125)I Seeds Articles Combined with Biliary Stent Implantation in the Treatment of Malignant Obstructive Jaundice. ( 28739766 )
2017
4
Advanced Roux-en-Y hepaticojejunostomy with magnetic compressive anastomats in obstructive jaundice dog models. ( 28779259 )
2017
5
Fine-needle aspiration findings of a rare hematopoietic neoplasm presenting as obstructive jaundice. ( 28752676 )
2017
6
Endoscopic ultrasound-guided choledochoduodenostomy for obstructive jaundice with venous collaterals around the bile duct wall (with video). ( 28440241 )
2017
7
Von Meyenburg complexes in a patient with obstructive jaundice. ( 28899322 )
2017
8
My First Patient: More Than Obstructive Jaundice. ( 28027099 )
2017
9
A late unusual complication after an open cholecystectomy: Amputation neuroma of the CBD causing obstructive jaundice. ( 28837915 )
2017
10
Preventing oxygen free radical damage by proanthocyanidin in obstructive jaundice. ( 28740952 )
2017
11
Multi-modality imaging-monitored creation of rat orthotopic pancreatic head cancer with obstructive jaundice. ( 28903340 )
2017
12
Cholangiohydatidosis: an Infrequent Cause of Obstructive Jaundice and Acute Cholangitis. ( 28425414 )
2017
13
Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice. ( 27874286 )
2017
14
A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. ( 28732391 )
2017
15
Obstructive Jaundice Caused by Hepatic Torsion in an Infant with Congenital Diaphragmatic Hernia. ( 28082781 )
2017
16
Effects of Different Palliative Jaundice Reducing Methods on Immunologic Functions in Patients with Advanced Malignant Obstructive Jaundice. ( 28739769 )
2017
17
Magnetic Resonance Cholangiopancreatography (MRCP) Evaluation of Obstructive Jaundice in Comparison with Endoscopic Retrograde Cholangiopancreatography (ERCP). ( 28588181 )
2017
18
Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice. ( 28948704 )
2017
19
A simple rat model of in situ reversible obstructive jaundice in situ reversible obstructive jaundice model. ( 28580342 )
2017
20
Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease. ( 28830135 )
2017
21
Lemmel's syndrome: Obstructive jaundice secondary to a duodenal diverticulum. ( 28341217 )
2017
22
Primary extrahepatic bile duct neuroendocrine tumor with obstructive jaundice masquerading as a Klatskin tumor. ( 28596824 )
2017
23
Hydrogen-rich saline protects against mitochondrial dysfunction and apoptosis in mice with obstructive jaundice. ( 26936224 )
2016
24
Hepatocellular Carcinoma With Budd-Chiari Syndrome and Obstructive Jaundice: A Therapeutic Challenge. ( 27661754 )
2016
25
Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting. ( 27107633 )
2016
26
Value of percutaneous transhepatic cholangiobiopsy for pathologic diagnosis of obstructive jaundice: analysis of 826 cases. ( 26917786 )
2016
27
Novel approach to recanalizing an occluded cystic duct after cholecystoduodenostomy by lumen-apposing metal mesh stent for malignant obstructive jaundice. ( 26684605 )
2016
28
A pilot study of intraluminal brachytherapy using (125)I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. ( 27364870 )
2016
29
Combined Stent Insertion and High-intensity Focused Ultrasound Ablation for Patients With Malignant Obstructive Jaundice. ( 27783026 )
2016
30
Immune dysfunction in patients with obstructive jaundice before and after endoscopic retrograde cholangiopancreatography. ( 27252406 )
2016
31
The role of growth factors on hepatic damage in rats with obstructive jaundice. ( 27540507 )
2016
32
Plasma BNP level combined with surgical Apgar score to predict operative major cardiac adverse events in malignant obstructive jaundice patients. ( 27882019 )
2016
33
Value and Accuracy of Multidetector Computed Tomography in Obstructive Jaundice. ( 27429673 )
2016
34
An Unusual Case of Obstructive Jaundice Owing to an Extrabiliary Mass. ( 27814999 )
2016
35
Obstructive jaundice caused by a pancreaticoduodenal pseudoaneurysm. ( 27324520 )
2016
36
Spontaneous Intramural Duodenal Hematoma: Pancreatitis, Obstructive Jaundice, and Upper Intestinal Obstruction. ( 27891286 )
2016
37
An uncommon cause of obstructive jaundice: An infrequent neoplastic etiology. ( 27637596 )
2016
38
Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. ( 27391646 )
2016
39
Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice. ( 27006124 )
2016
40
Obstructive Jaundice as a Complication of Macrocystic Serous Cystadenoma of the Pancreas. ( 27550882 )
2016
41
Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients. ( 27241392 )
2016
42
Murine model of long-term obstructive jaundice. ( 27916350 )
2016
43
Comment re: "Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting". ( 27329667 )
2016
44
Gastrointestinal bleeding and obstructive jaundice: Think of hepatic artery aneurysm. ( 27358680 )
2016
45
Uterine cancer presenting as obstructive jaundice. ( 27462179 )
2016
46
Ginsenoside Rg1 prevents cerebral and cerebellar injury induced by obstructive jaundice in rats via inducing expression of TIPE-2. ( 26592478 )
2016
47
Cost Effectiveness of Metal Stents in Relieving Obstructive Jaundice in Patients with Pancreatic Cancer. ( 28025817 )
2016
48
An interesting case of obstructive jaundice. ( 27728263 )
2016
49
Aggressive Surgery for Locally Advanced Gallbladder Cancer with Obstructive Jaundice: Result of a Prospective Study. ( 26918527 )
2016
50
Comparison Of Ultrasound Evaluation Of Patients Of Obstructive Jaundice With Endoscopic Retrograde Cholangio-Pancreatography Findings. ( 28586609 )
2016

Variations for Obstructive Jaundice

Expression for Obstructive Jaundice

Search GEO for disease gene expression data for Obstructive Jaundice.

Pathways for Obstructive Jaundice

GO Terms for Obstructive Jaundice

Cellular components related to Obstructive Jaundice according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.61 ALB CXCL8 EDN1 F2 HGF IL6
2 external side of plasma membrane GO:0009897 9.46 CD79A F2 IL6 TNF
3 extracellular space GO:0005615 9.36 ALB CXCL8 EDN1 F2 GGT1 GPT

Biological processes related to Obstructive Jaundice according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.63 EDN1 IL6 TNF
2 cellular protein metabolic process GO:0044267 9.56 ALB F2 IL6 TTR
3 cellular response to interleukin-1 GO:0071347 9.5 CXCL8 EDN1 IL6
4 positive regulation of chemokine production GO:0032722 9.48 IL6 TNF
5 cellular response to hepatocyte growth factor stimulus GO:0035729 9.43 HGF IL6
6 negative regulation of hormone secretion GO:0046888 9.4 EDN1 IL6
7 negative regulation of lipid storage GO:0010888 9.37 IL6 TNF
8 positive regulation of smooth muscle cell proliferation GO:0048661 9.33 EDN1 IL6 TNF
9 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 8.96 IL6 TNF
10 positive regulation of nitric oxide biosynthetic process GO:0045429 8.8 EDN1 IL6 TNF

Molecular functions related to Obstructive Jaundice according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.92 CXCL8 EDN1 IL6 TNF

Sources for Obstructive Jaundice

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....